Cancer Profiling Market Eyes Substantial Expansion, Envisioning 11.5% CAGR Through 2030

Cancer Profiling Market Eyes Substantial Expansion, Envisioning 11.5% CAGR Through 2030

Global Cancer Profiling Market Share Size, and Future Landscape

MarkNtel Advisors, a leading market research company, presents its latest Global Cancer Profiling Market Research Report By Type of Cancer (Breast Cancer, Colorectal Cancer, Gynecological Cancer, Leukemia, Prostate Cancer, Lung Cancer, Others), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays Analysis) and other forecasts [2024-2030]. This well-curated report contains in-depth information about the industry. In this comprehensive study, we have meticulously compiled every critical detail, catering to the Cancer Profiling Market’s major and minor elements. Our focus extends to factors influencing market growth, encompassing historical, current, and projected data, emerging trends, technological advancements, key insights, recent developments, potential constraints, and various other factors that could significantly shape the industry’s trajectory in the foreseeable future.

Cancer Profiling Market Insight:

The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30.

Visit for Free Sample Report – https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html

Competitive Landscape – Global Cancer Profiling Market

This section provides a comprehensive understanding of market dynamics, highlighting the significant contributions of major companies and their strategies for achieving success and sustainability. By examining the competitive landscape, clients can gain valuable insights into the driving forces behind the growth and evolution of the Cancer Profiling Industry. Let’s familiarize ourselves with the key players in this competitive landscape: NeoGenomics Laboratories, Eurofins Genomics GmbH, F. Hoffmann-La Roche Ltd (Foundation Medicine) , OncoDNA SA, 10x Genomics, Inc., Caris Life Sciences., Geneseeq Technology Inc., Genetron , Holdings Limited, Laboratory Corporation of America Holdings (LabCorp), Dante Labs Inc., Celemics, Inc., Strand Life Sciences, Myriad Genetics, Inc., QIAGEN GmbH, Tempus Labs, Others.

Global Cancer Profiling Market Trend

Introduction of Single Cell Genomics Technique Fueled the Market Growth – The introduction of advanced kits and instruments for the identification of single-cell profiling revolutionized the cancer profiling services market in recent years. The single-cell profiling technologies allow the user to identify a complete study of a single cell, in contrast to providing an average measurement of genomic and proteomic information obtained from traditional techniques.

These techniques allow researchers and healthcare professionals to understand the cellular diversity, and how different cells contribute to the origin of diseases, especially across the oncology segment. Hence, observing this interest of researchers in single-cell technologies, companies like Singular Genomics Systems, Inc., Honeycomb Biotechnologies, 10x Genomics, etc., are introducing their advanced kits and instruments for such studies. For instance,

  • In 2023, Singular Genomics Systems, Inc., launched its Max Read™ Kits designed for single-cell applications, which enhances sequencing capacity, achieving an industry-leading 3.2 billion reads per run for benchtop single-cell sequencing.

Hence, the introduction of single-cell sequencing techniques has considerably improved the output of cancer profiling services and has contributed to its improved market growth in recent years. Further, the single-cell techniques are projected to open new arenas of applications of cancer profiling services, which would allow further expansion of their adoption, and would create an opportunity for the growth of the Global Cancer Profiling Market in the coming years.

View Full Report [Include Description + TOC], – https://www.marknteladvisors.com/research-library/cancer-profiling-market.html

Segmentation Summary – Cancer Profiling Market

The summary of Cancer Profiling market segmentation gives a quick look at different parts of the market. It helps businesses understand what customers like and where they are. By breaking down the market into smaller groups based on things like what people buy and where they live, companies can make better plans to sell their products. This summary is a simple guide to understanding the market better. The segmentations of the market are:

Technology

 > Next-Generation Sequencing – Market Size & Forecast 2019-2030, USD Million

 > Polymerase Chain Reaction – Market Size & Forecast 2019-2030, USD Million

 > Mass Spectrometry – Market Size & Forecast 2019-2030, USD Million

 > In-Situ Hybridization – Market Size & Forecast 2019-2030, USD Million

 > Microarrays Analysis – Market Size & Forecast 2019-2030, USD Million

 > Others (Single-Cell Sequencing, etc.) – Market Size & Forecast 2019-2030, USD Million

Biomarker Type

 > Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million

 > Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million

 > Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million

Cell Type

 > Germline – Market Size & Forecast 2019-2030, USD Million

 > Somatic – Market Size & Forecast 2019-2030, USD Million

Application

 > Oncology Research – Market Size & Forecast 2019-2030, USD Million

 > Precision Medicine – Market Size & Forecast 2019-2030, USD Million

 > Clinical Diagnostics – Market Size & Forecast 2019-2030, USD Million

 > Others (Prognosis, Monitoring and Recurrence Detection, etc.) – Market Size & Forecast 2019-2030, USD Million

End-User

 > Hospitals and Clinics – Market Size & Forecast 2019-2030, USD Million

 > Research Institutions and Laboratories – Market Size & Forecast 2019-2030, USD Million

 > Diagnostic Service Providers – Market Size & Forecast 2019-2030, USD Million

 > Pharmaceutical and Biotechnology Companies – Market Size & Forecast 2019-2030, USD Million

Type of Cancer

 > Breast Cancer – Market Size & Forecast 2019-2030, USD Million

 > Colorectal Cancer – Market Size & Forecast 2019-2030, USD Million

 > Gynecological Cancer – Market Size & Forecast 2019-2030, USD Million

 > ‎Leukemia – Market Size & Forecast 2019-2030, USD Million

 > Prostate Cancer – Market Size & Forecast 2019-2030, USD Million

 > Lung Cancer – Market Size & Forecast 2019-2030, USD Million

 > Others (Pancreatic Cancer, Skin Cancer, etc.) – Market Size & Forecast 2019-2030, USD Million

Based on Type of Cancer: Prostate cancer segment has the largest market share in the Global Cancer Profiling Market, which is attributed to the increasing prevalence of the segment globally. Prostate cancer has been one of the most common types of cancer in men, which requires early diagnosis to determine treatment methods for this specific cancer..

Geographical landscape

On the geographical front, the Cancer Profiling Market expands across:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Of all regions globally, North America has been dominating the Global Cancer Profiling Market over the historical years. This has been mainly attributed to the unhealthy lifestyle of consumers, which has been leading to the rising prevalence of cancer across the region.

If you need more specific details that aren’t already in the report, we’re here to help! Just “Sent Your Inquiry” to let us know what you’re looking for, and we’ll be happy to customize the report to meet your needs.

Key Questions Addressed in this Cancer Profiling Market Report:

  • What are the emerging trends in the Cancer Profiling Industry?
  • What are the growth challenges faced by businesses in the Cancer Profiling Industry?
  • How can companies capitalize on opportunities within the market of Cancer Profiling?
  • What are the regulatory factors impacting the growth of the Cancer Profiling Market?
  • What are some of the top Cancer Profiling companies in the global market?
  • What is the current size of the Cancer Profiling Market and how much is it will grow in the next few years?

Browse Other Reports:

About us –

We are a leading consulting, data analytics, and market research Company that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us –

Call: +1 628 895 8081 +91 120 4278433

 

Email: [email protected]